Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
about
In vitro microtumors provide a physiologically predictive tool for breast cancer therapeutic screeningProbing the behaviors of gold nanorods in metastatic breast cancer cells based on UV-vis-NIR absorption spectroscopy.Comparison of cantharidin toxicity in breast cancer cells to two common chemotherapeuticsProteomic studies in breast cancer (Review).Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells.The Na⁺/H⁺ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cellsDNA damage and breast cancerOverexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma.Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinomaSynthesis, characterization, and evaluation of cis-diphenyl pyridineamine platinum(II) complexes as potential anti-breast cancer agentsCyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma.Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy.MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.Novel functional assay for spindle-assembly checkpoint by cyclin-dependent kinase activity to predict taxane chemosensitivity in breast tumor patient.Taxane benefit in breast cancer--a role for grade and chromosomal stability.Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer.Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.Thymoquinone restores radiation-induced TGF-β expression and abrogates EMT in chemoradiotherapy of breast cancer cells.Dysadherin expression promotes the motility and survival of human breast cancer cells by AKT activation.Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors.Regulation of paclitaxel sensitivity in prostate cancer cells by PTEN/maspin signaling.High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascade.
P2860
Q28545989-19BC4E98-B54D-4008-BF46-142850232C23Q34182128-53C2951B-E853-4B91-8628-E6845560CACDQ34267632-7DCE90D3-D374-4DE4-A3B3-A27B08658C8BQ34319634-EBB428D5-467B-4560-ADC8-27836CE7BE5CQ34590906-684D555B-A752-4EEE-9D01-DFEC3E328B44Q35176066-6373F5EF-4D8C-4D53-82C9-322CF1CAA0A3Q35201664-828C2A6A-1D13-4EC2-A36F-363270F426BEQ35835123-7CEC19DD-F9B1-4BDF-9D61-10CE97AED919Q35848667-518F803A-BB3A-4209-908A-1FFDE0168196Q36270717-079AB1C7-E49A-48CE-A893-53BC9D72B6E6Q36424035-E3F6F008-CE96-45CC-ABE0-ED4AF333DE1DQ36750990-735D852F-9804-4681-9543-118A36CD5BACQ36905747-F43A4740-908A-46AA-ABAB-EA4A87F0586EQ37347521-8158F845-945E-44F6-BBBF-3357B72C7667Q38104568-81CEADB8-D615-4D98-ACC1-56A95A92D160Q38762630-1BBCC97C-1F8F-41CC-8F47-864B577531B3Q38852131-BE001EB1-805C-467D-996A-1BFAB33E731FQ38962304-DA6FC7E4-58E4-412F-A075-74BA0FBCADF6Q39365972-72889C56-0B5D-4AD1-B01D-2C5105AC65D8Q40931694-EBE42557-6A22-4C8B-94AE-15B706C5CAF8Q42739081-AAA473FB-F519-4234-A5EE-ACE77F66E91BQ43675251-31130771-1D7A-455E-9E5F-9A609791C367Q47961317-AA99E8C0-10FA-4BAB-AFD1-3B1C734A38FAQ48227330-27B7CB5F-88C2-4311-9D84-BD5F30E25531
P2860
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prediction of paclitaxel sensi ...... y in human breast cancer cells
@en
Prediction of paclitaxel sensi ...... in human breast cancer cells.
@nl
type
label
Prediction of paclitaxel sensi ...... y in human breast cancer cells
@en
Prediction of paclitaxel sensi ...... in human breast cancer cells.
@nl
prefLabel
Prediction of paclitaxel sensi ...... y in human breast cancer cells
@en
Prediction of paclitaxel sensi ...... in human breast cancer cells.
@nl
P2093
P2860
P356
P1476
Prediction of paclitaxel sensi ...... y in human breast cancer cells
@en
P2093
Aya Katayama
Gabriel N Hortobagyi
Hideki Ishihara
Keigo Gohda
Naoto T Ueno
Satoshi Nakayama
Shinzaburo Noguchi
Takeshi Takahashi
Tamotsu Sudo
Tomokazu Yoshida
P2860
P2888
P356
10.1186/BCR2231
P577
2009-02-24T00:00:00Z
P5875
P6179
1036529065